Clinical Trial Update: Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating liposomal irinotecan (Nal-IRI) for brain metastases in breast cancer patients, assessing effi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Onivyde (liposomal irinotecan) (liposomal irinotecan)

Snippet

Sponsor: MedSIR | Conditions: Breast Cancer Metastatic | Phase 2 | Status: COMPLETED